Comment donner du poids à vos messages sur la tuberculose
WHO/HTM/STB/2009.57
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...risk of continued Ebola virus transmission. WHO has developed this document to guide health services on how to provide quality care to survivors of Ebola virus disease
more
In this review, the editors will investigate the impact of eight WASH interventions in preventing (reducing the risk of) and controlling outbreaks in LMIC, with particular focus on three diseases of current concern to the response community – cholera, Ebola, and Hepatitis E. Additionally, we will ...explore economic outcomes related to WASH interventions within an outbreak
more
Cet ouvrage est l’adaptation en langue française d’un des livres les plus demandés de l’OMS: Surgical Care at the District Hospital. Il y a longtemps qu’il était attendu notamment par l’Afrique francophone. En effet l’ambition de ce livre est de contribuer à corriger l’insuffisance... des soins d’urgence et de chirurgie de base fréquemment constatée dans les pays les plus démunis
more
Élargir l’accès aux soins pour
lutter contre les troubles mentaux,
neurologiques et liés à l’utilisation
de substances psychoactives
Plus de 2000 enfants meurent chaque jour des suites de traumatismes involontaires ou accidentels. Chaque année des dizaines de milliers d'autres sont hospitalisés pour des blessures qui les laissent souvent handicapés à vie.
Ce rapport conjoint de l'OMS et de l'UNICEF établit le premier b...ilan mondial des principales causes à l'origine des traumatismes involontaires touchant des enfants: les accidents de la route, les noyades, les brûlures, les chutes et les empoisonnements.
more
A l’attention des professionnels soignants, des formateurs et des observateurs des pratiques d’hygiène des mains
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...with non-severe COVID-19 as the treatment brought no benefits, and could even prove harmful. Treatment should be under supervision of a clinician.
Corticosteroids are listed in the WHO model list of essential medicines, readily available globally at a low cost. WHO encourages countries to maintain sufficient stocks of corticosteroids to treat COVID-19 and the other disease for which they are effective, while not maintaining excessive stocks which could deny other countries access.
more
The rapid arrival of millions of asylum seekers and migrants in Europe in 2015–16 forced cities both large and small to rethink their approach to immigrant inclusion.
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...le globally and is highly prevalent in Latin America where most cases are reported. However, there is increasing evidence that Chagas disease is now an important public health issue outside the “classical” endemic countries due to population migration. Our understanding of Chagas disease, including its pathologies and factors relating to progression, remains to date limited, and is also challenged by lack of diagnosis and highly effective treatment. This systematic review aims to describe studies with Chagas patients receiving antiparasitic treatment. Databases were searched for relevant studies published after 1997, and the results of these searches were screened.
more
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address the many outstanding resea...rch questions. This systematic review aims to describe the characteristics and treatment practices of clinical studies in CD and assess the breadth and availability of research data for the potential establishment of a data-sharing platform.
more